Search

Your search keyword '"CHU Bordeaux [Bordeaux]-Université Sciences et Technologies - Bordeaux 1"' showing total 13 results

Search Constraints

Start Over You searched for: Author "CHU Bordeaux [Bordeaux]-Université Sciences et Technologies - Bordeaux 1" Remove constraint Author: "CHU Bordeaux [Bordeaux]-Université Sciences et Technologies - Bordeaux 1"
13 results on '"CHU Bordeaux [Bordeaux]-Université Sciences et Technologies - Bordeaux 1"'

Search Results

1. Mutations of the integrin αIIb/β3 intracytoplasmic salt bridge cause macrothrombocytopenia and enlarged platelet α-granules

2. Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

3. The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism

4. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry

5. Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission

6. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

7. Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series

8. Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia

9. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry

10. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention

11. Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

12. Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

13. Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection

Catalog

Books, media, physical & digital resources